![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/473 | (2006.01) |
A61K 9/4825 | (2013.01) | ||
A61P 37/00 | (2006.01) | ||
A61K 31/403 | (2013.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 17/10 | (2018.01) | ||
A61P 17/06 | (2018.01) | ||
A61P 37/02 | (2018.01) | ||
A61P 19/02 | (2018.01) | ||
A61P 3/10 | (2018.01) | ||
A61P 29/00 | (2018.01) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 3242666 |
(13) | Kind of document | T |
(96) | European patent application number | 16700936.4 |
Date of filing the European patent application | 2016-01-06 | |
(97) | Date of publication of the European application | 2017-11-15 |
(45) | Date of publication and mention of the grant of the patent | 2024-10-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/012289 |
Date | 2016-01-06 |
(87) | Number | WO 2016/112075 |
Date | 2016-07-14 |
(30) | Number | Date | Country code |
201562100362 P | 2015-01-06 | US | |
201562159550 P | 2015-05-11 | US |
(72) |
GLICKLICH, Alan , US
KAM, Maria Matilde Sanchez , US
SHANAHAN, William R. , US
|
(73) |
Arena Pharmaceuticals, Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
(54) | COMPOUND FOR USE IN TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR |
COMPOUND FOR USE IN TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR |